Vitacost.com receives NASDAQ noncompliance notification letter

Vitacost.com, Inc. (NASDAQ: VITC), a leading online retailer and direct marketer of health and wellness products, announced today that the Company received an additional letter from The NASDAQ Stock Market ("NASDAQ") indicating that the Company is not in compliance with Listing Rule 5250(c) due to the delinquent filing of the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2011 (the "Quarterly Report").

As previously announced, on December 21, 2010, the Company received a letter from NASDAQ indicating that the NASDAQ staff had determined that continued listing of the Company's securities on The NASDAQ Stock Market was no longer warranted. The Company timely appealed the Staff determination, and requested a hearing before a NASDAQ Hearings Panel (the "Panel"), which was held on February 3, 2011. On February 28, 2011, the Company received written notice that the Panel had determined to grant the request of the Company to remain listed on The NASDAQ Stock Market, subject to certain conditions.

The Additional Staff Determination Letter, which the Company expected, advised that the Panel will consider the Company's failure to timely file the Quarterly Report in their decision regarding the continued listing of the Company's securities on The NASDAQ Stock Market. The Company has until May 25, 2011 to present its views with respect to this additional deficiency to the Panel. The Company intends to respond to the request in a timely manner.

Source:

 Vitacost.com, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.